Total Payments
$702.86
2024 Payments
$213.48
Companies
15
Transactions
34
Medicare Patients
4,036
Medicare Billing
$463,266
Payment Breakdown by Category
Food & Beverage$682.86 (97.2%)
Other$20.00 (2.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $682.86 | 33 | 97.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $20.00 | 1 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $101.94 | 8 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $94.97 | 1 | $0 (2019) |
| Laborie Medical Technologies Corp. | $88.68 | 2 | $0 (2024) |
| Medtronic, Inc. | $87.49 | 1 | $0 (2024) |
| Janssen Biotech, Inc. | $65.11 | 4 | $0 (2024) |
| Synergy Pharmaceuticals Inc | $51.02 | 4 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $42.20 | 3 | $0 (2019) |
| Daiichi Sankyo Inc. | $41.09 | 3 | $0 (2023) |
| ABBVIE INC. | $34.00 | 2 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $21.79 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $213.48 | 5 | Laborie Medical Technologies Corp. ($88.68) |
| 2023 | $77.41 | 5 | Janssen Biotech, Inc. ($32.99) |
| 2022 | $29.09 | 2 | Janssen Biotech, Inc. ($14.81) |
| 2019 | $197.54 | 9 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($94.97) |
| 2018 | $133.12 | 10 | Synergy Pharmaceuticals Inc ($39.48) |
| 2017 | $52.22 | 3 | Valeant Pharmaceuticals North America LLC ($21.79) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ABBVIE INC. | CREON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $20.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: Immunology | ||||||
| 06/17/2024 | Laborie Medical Technologies Corp. | — | Food and Beverage | Cash or cash equivalent | $39.19 | General |
| 06/06/2024 | Laborie Medical Technologies Corp. | EverLift (Device) | Food and Beverage | Cash or cash equivalent | $49.49 | General |
| Category: Gastroenterology | ||||||
| 04/15/2024 | Medtronic, Inc. | ENDOFLIP (Device) | Food and Beverage | In-kind items and services | $87.49 | General |
| Category: Motility Testing | ||||||
| 12/21/2023 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/01/2023 | AbbVie Inc. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/12/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Immunology | ||||||
| 04/26/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Immunology | ||||||
| 01/10/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Iron Deficiency Anemia | ||||||
| 06/27/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Immunology | ||||||
| 06/15/2022 | PFIZER INC. | XELJANZ (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/30/2019 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/28/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $94.97 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/01/2019 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Anemia | ||||||
| 06/10/2019 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 05/22/2019 | Ironwood Pharmaceuticals, Inc | Linzess (Drug), Viberzi | Food and Beverage | In-kind items and services | $11.36 | General |
| Category: Gastroenterology | ||||||
| 04/27/2019 | Covidien LP | Bravo (Device) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: Ablation | ||||||
| 04/03/2019 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 02/06/2019 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/04/2019 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $10.91 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/20/2018 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $11.57 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/26/2018 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/10/2018 | Synergy Pharmaceuticals Inc | Trulance (Drug) | Food and Beverage | In-kind items and services | $10.63 | General |
| Category: Gastroenterology | ||||||
| 08/20/2018 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,037 | 1,181 | $780,192 | $117,433 |
| 2022 | 14 | 1,032 | 1,157 | $659,425 | $103,007 |
| 2021 | 16 | 1,086 | 1,265 | $911,881 | $135,539 |
| 2020 | 15 | 881 | 989 | $723,525 | $107,287 |
Total Patients
4,036
Total Services
4,592
Medicare Billing
$463,266
Procedure Codes
61
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 201 | 256 | $89,344 | $25,704 | 28.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 79 | 80 | $151,800 | $16,151 | 10.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 116 | 116 | $185,020 | $10,897 | 5.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 73 | 73 | $32,120 | $10,002 | 31.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 102 | 144 | $33,120 | $9,598 | 29.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 78 | 81 | $35,478 | $8,767 | 24.7% |
| 76981 | Ultrasound scan of organ tissue for measuring elasticity | Office | 2023 | 75 | 77 | $27,986 | $6,712 | 24.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 86 | 100 | $23,500 | $6,500 | 27.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 31 | 54 | $17,928 | $5,277 | 29.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 25 | 25 | $42,350 | $4,705 | 11.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 48 | 48 | $87,120 | $4,373 | 5.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 58 | 58 | $20,416 | $4,210 | 20.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 16 | 16 | $27,104 | $2,200 | 8.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 22 | 23 | $3,289 | $1,013 | 30.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 16 | 19 | $2,356 | $804.08 | 34.1% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 11 | 11 | $1,262 | $519.64 | 41.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 119 | 143 | $49,907 | $13,682 | 27.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 171 | 223 | $51,290 | $13,449 | 26.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 57 | 58 | $110,055 | $12,398 | 11.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 109 | 110 | $175,450 | $11,091 | 6.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 86 | 86 | $37,668 | $9,842 | 26.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 75 | 75 | $33,000 | $9,175 | 27.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 96 | 96 | $33,792 | $9,010 | 26.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 118 | 128 | $30,080 | $8,971 | 29.8% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 81 | 116 | $14,384 | $3,834 | 26.7% |
About Dr. Edgar Bigornia, M.D
Dr. Edgar Bigornia, M.D is a Gastroenterology healthcare provider based in Toms River, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1639116973.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Edgar Bigornia, M.D has received a total of $702.86 in payments from pharmaceutical and medical device companies, with $213.48 received in 2024. These payments were reported across 34 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($682.86).
As a Medicare-enrolled provider, Bigornia has provided services to 4,036 Medicare beneficiaries, totaling 4,592 services with total Medicare billing of $463,266. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Toms River, NJ
- Active Since 06/02/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1639116973
Products in Payments
- XELJANZ (Drug) $101.94
- XIFAXAN (Drug) $94.97
- ENDOFLIP (Device) $87.49
- Trulance (Drug) $51.02
- EverLift (Device) $49.49
- STELARA (Biological) $47.80
- DIFICID (Drug) $42.20
- INJECTAFER (Drug) $41.09
- XIFAXANIBSD (Drug) $21.79
- CREON (Drug) $20.00
- Cresemba (Drug) $18.89
- TREMFYA (Drug) $17.31
- REBYOTA (Biological) $16.51
- OCALIVA (Drug) $14.58
- RINVOQ (Biological) $14.00
- Bravo (Device) $13.23
- Linzess (Drug) $11.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Toms River
Mr. Neil Nagaria, Md, MD
Gastroenterology — Payments: $18,349
Gastroenterology $18,349
Teresa Tacopina, Md, MD
Gastroenterology — Payments: $7,735
Gastroenterology $7,735
Dr. Eric Eschinger, Md, MD
Gastroenterology — Payments: $6,236
Gastroenterology $6,236
Kenneth Glazier
Gastroenterology — Payments: $5,912
Gastroenterology $5,912
Carl Raso, Md, MD
Gastroenterology — Payments: $5,227
Gastroenterology $5,227
Gabrielle Corpuz, Pa-C, PA-C
Gastroenterology — Payments: $4,258
Gastroenterology $4,258